PMVP Pmv Pharmaceuticals, Inc.

Fundamentals / CIK 0001699382 / USD

Pmv Pharmaceuticals, Inc. reported $111.4M in total assets and a net loss of $88.53M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PMVP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$0$0$0-$72.69MFY 2018 Net Income: -$17.54M2018FY 2019 Net Income: -$25.35M2019FY 2020 Net Income: -$34.44M2020FY 2021 Net Income: -$57.85M2021FY 2022 Net Income: -$73.32M2022FY 2023 Net Income: -$68.96M2023FY 2024 Net Income: -$58.71M2024FY 2025 Net Income: -$77.74M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $69.88M $58.53M $55.88M $51.99M $36.49M $23.93M $20.76M $13.85M
Total Operating Expenses $86.21M $85.45M $80.13M $77.04M $58.29M $34.94M $26.64M $18.89M
Operating Income -$86.21M -$85.45M -$80.13M -$77.04M -$58.29M -$34.94M -$26.64M -$18.89M
EBITDA -$86.07M -$84.30M -$78.88M -$76.72M -$57.99M -$34.62M -$26.25M -$18.55M
Income Before Tax -$79.91M -$74.81M -$68.96M -$73.33M -$57.82M -$34.43M -$25.34M -$17.54M
Income Tax Expense -$2.17M -$16.10M $2.0K -$9.0K $23K $6.0K $8.0K $3.0K
Net Income -$77.74M -$58.71M -$68.96M -$73.32M -$57.85M -$34.44M -$25.35M -$17.54M
Basic EPS -$1.48 -$1.14 -$1.44 -$1.61 -$1.28 -$2.40 -$8.35 -$5.82
Diluted EPS -$1.48 -$1.14 -$1.44 -$1.61 -$1.28 -$2.40 -$8.35 -$5.82
Basic Shares Outstanding 52.5M 51.6M 48.0M 45.6M 45.1M 14.4M 3.0M 3.0M
Diluted Shares Outstanding 52.5M 51.6M 48.0M 45.6M 45.1M 14.4M 3.0M 3.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $16.06M $14.68M $15.33M $15.83M $18.21M $18.40M $17.44M $13.77M
Total Operating Expenses $20.06M $18.88M $19.02M $19.24M $22.52M $22.88M $21.56M $25.17M
Operating Income -$20.06M -$18.88M -$19.02M -$19.24M -$22.52M -$22.88M -$21.56M -$25.17M
EBITDA -$20.04M -$18.86M -$18.98M -$19.21M -$22.49M -$22.85M -$21.53M -$25.13M
Income Before Tax -$34.38M -$18.08M -$18.04M -$18.01M -$21.07M -$21.20M -$19.63M -$23.00M
Income Tax Expense -$7.0K $3.0K -- $26K -$6.0K $5.0K -$2.20M --
Net Income -$34.37M -$18.09M -$18.04M -$18.04M -$21.06M -$21.21M -$17.44M -$23.00M
Basic EPS -$0.52 -$0.34 -$0.34 -- -$0.40 -$0.41 -$0.34 --
Diluted EPS -$0.52 -$0.34 -$0.34 -- -$0.40 -$0.41 -$0.34 --
Basic Shares Outstanding 66.2M 53.4M 53.3M -- 53.0M 52.0M 52.0M --
Diluted Shares Outstanding 66.2M 53.4M 53.3M -- 53.0M 52.0M 52.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $37.98M $40.88M $37.71M $108.3M $172.5M $361.4M $73.28M
Short-Term Investments $74.96M $128.6M $165.4M $132.8M $124.7M -- $28.21M
Cash & Short-Term Investments $112.9M $183.3M $228.6M $243.5M $314.1M $361.4M $101.5M
Total Current Assets $115.2M $175.7M $207.4M $247.0M $301.3M $364.8M $102.1M
Property, Plant & Equipment, Net $237K $409K $10.67M $10.96M $3.09M $569K $739K
Long-Term Investments $0 $13.84M $25.50M $2.50M $16.91M -- --
Other Non-Current Assets $297K $235K $190K $313K $221K $201K $201K
Total Non-Current Assets $1.33M $15.63M $44.74M $23.30M $30.28M $770K $940K
Total Assets $116.6M $191.3M $252.2M $270.3M $331.6M $365.5M $103.0M
Accounts Payable $3.15M $6.58M $3.24M $3.00M $3.19M $1.61M $2.84M
Total Current Liabilities $11.41M $14.37M $14.03M $10.83M $12.22M $6.41M $4.52M
Other Non-Current Liabilities -- -- -- -- -- -- $51K
Total Non-Current Liabilities $435K $838K $12.43M $13.45M $10.79M $0 $51K
Total Liabilities $11.85M $15.21M $26.46M $24.28M $23.01M $6.41M $4.57M
Total Debt (incl. Leases) $838K $1.19M $13.29M $13.98M $11.19M -- --
Retained Earnings -$446.5M -$368.7M -$310.0M -$241.0M -$167.7M -$109.9M -$75.44M
Accumulated Other Comp. Income $84K $139K $224K -$445K -$78K -- -$3.0K
Total Stockholders' Equity $104.7M $176.1M $225.7M $246.0M $308.6M $359.1M -$70.47M
Total Equity $104.7M $176.1M $225.7M $246.0M $308.6M $359.1M -$70.47M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $19.99M $12.47M $39.13M $37.98M $36.34M $44.13M $51.34M $40.88M
Short-Term Investments $82.57M $66.96M $54.42M $74.96M $92.91M $98.15M $109.0M $128.6M
Cash & Short-Term Investments $108.5M $79.43M $93.55M $112.9M $129.2M $148.3M $165.8M $183.3M
Total Current Assets $104.9M $81.41M $95.78M $115.2M $132.4M $145.3M $163.5M $175.7M
Property, Plant & Equipment, Net $131K $154K $203K $237K $255K $287K $376K $409K
Long-Term Investments $5.96M $0 $0 $0 $0 $6.03M $5.43M $13.84M
Other Non-Current Assets $291K $296K $296K $297K $249K $248K $237K $235K
Total Non-Current Assets $6.51M $659K $782K $1.33M $1.40M $7.54M $7.11M $15.63M
Total Assets $111.4M $82.07M $96.56M $116.6M $133.8M $152.9M $170.6M $191.3M
Accounts Payable $1.64M $2.02M $1.63M $3.15M $3.40M $2.60M $3.59M $6.58M
Total Current Liabilities $10.69M $10.57M $8.60M $11.41M $12.30M $11.61M $9.76M $14.37M
Total Non-Current Liabilities $43.61M $0 $0 $435K $541K $643K $742K $838K
Total Liabilities $54.30M $10.57M $8.60M $11.85M $12.85M $12.25M $10.50M $15.21M
Total Debt (incl. Leases) $138K $217K $293K $838K $931K $1.02M $1.11M $1.19M
Retained Earnings -$517.0M -$482.6M -$464.5M -$446.5M -$428.4M -$407.4M -$386.1M -$368.7M
Accumulated Other Comp. Income -$156K -$82K -$15K $84K $91K $21K $84K $139K
Total Stockholders' Equity $57.11M $71.50M $87.97M $104.7M $121.0M $140.6M $160.1M $176.1M
Total Equity $57.11M $71.50M $87.97M $104.7M $121.0M $140.6M $160.1M $176.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$77.74M -$58.71M -$68.96M -$73.32M -$57.85M -$34.44M -$25.35M -$17.54M
Depreciation & Amortization $133K $1.14M $1.26M $315K $307K $318K $388K $338K
Stock-Based Compensation $5.92M $8.87M $12.38M $10.20M $5.34M $1.93M $908K $1.08M
Change in Payables -$3.42M $3.34M $235K -$389K $191K -$1.23M $1.80M $267K
Operating Cash Flow -$73.58M -$51.28M -$55.66M -$63.76M -$46.57M -$32.74M -$22.07M -$15.18M
Capital Expenditure -$29K -$655K -$962K -$7.98M -$1.35M -$148K -$109K -$452K
Free Cash Flow -$73.61M -$51.94M -$56.62M -$71.74M -$47.92M -$32.89M -$22.17M -$15.63M
Purchases of Investments -$88.20M -$148.3M -$220.5M -$229.2M -$256.8M -$14.51M -$43.45M -$48.68M
Investing Cash Flow $70.17M $53.35M -$50.55M -$1.37M -$143.6M $27.91M $3.23M $21.69M
Common Stock Issued -- -- $35.12M -- -- $223.2M -- --
Financing Cash Flow $505K $313K $35.58M $958K $2.02M $293.0M $61.80M --
Net Change in Cash -$2.89M $2.35M -$70.59M -$64.17M -$188.1M $288.1M $42.97M $6.51M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$34.37M -$18.09M -$18.04M -$18.04M -$21.06M -$21.21M -$17.44M -$23.00M
Depreciation & Amortization $23K $24K $34K $33K $32K $32K $37K $39K
Stock-Based Compensation $1.60M $1.54M $1.39M $1.36M $1.38M $1.67M $1.51M $1.27M
Change in Payables -$382K $389K -$1.52M -$244K $801K -$995K -$2.99M $4.52M
Operating Cash Flow -$18.18M -$14.58M -$19.68M -$17.19M -$19.82M -$18.30M -$18.27M -$16.66M
Capital Expenditure $0 $0 $0 -$15K $1.0K -$11K -$4.0K -$56K
Free Cash Flow -$18.18M -$14.58M -$19.68M -$17.20M -$19.82M -$18.31M -$18.27M -$16.72M
Purchases of Investments -$41.16M -$26.73M -$10.68M -$21.04M -$20.47M -$30.96M -$15.73M -$37.51M
Investing Cash Flow -$21.20M -$12.23M $20.82M $18.44M $12.03M $10.99M $28.71M $7.74M
Financing Cash Flow $46.91M $143K $0 $392K $0 $103K $10K $172K
Net Change in Cash $7.53M -$26.66M $1.15M $1.65M -$7.79M -$7.21M $10.46M -$8.76M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -74.2% -33.3% -30.6% -29.8% -18.7% -9.6% -- --
Return on Assets (ROA) -66.7% -30.7% -27.3% -27.1% -17.4% -9.4% -24.6% --
Current Ratio 10.09x 12.22x 14.78x 22.80x 24.66x 56.90x 22.57x --
Quick Ratio 9.89x 12.76x 16.29x 22.48x 25.70x 56.38x 22.44x --
Debt to Equity 0.01x 0.01x 0.06x 0.06x 0.04x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -155.0% -105.2% -89.1% -74.2% -68.4% -57.5% -38.0% -33.3%
Return on Assets (ROA) -79.5% -91.7% -81.1% -66.7% -61.8% -52.9% -35.7% -30.7%
Current Ratio 9.81x 7.70x 11.14x 10.09x 10.76x 12.52x 16.75x 12.22x
Quick Ratio 10.15x 7.52x 10.88x 9.89x 10.50x 12.78x 16.99x 12.76x
Debt to Equity 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001699382) · from December 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal